Mechanisms limiting distribution of the threonine-protein kinase B-RaF V600E inhibitor dabrafenib to the brain: Implications for the treatment of melanoma brain metastases
Rajendar K. Mittapalli, Shruthi Vaidhyanathan, Arkadiusz Z Dudek, William F. Elmquist
Dive into the research topics of 'Mechanisms limiting distribution of the threonine-protein kinase B-RaF V600E inhibitor dabrafenib to the brain: Implications for the treatment of melanoma brain metastases'. Together they form a unique fingerprint.